| Date | Broker name | New | Price | Old price target | New price target | Broker change |
|---|---|---|---|---|---|---|
| 03-Nov-25 | Berenberg Bank | Sell | 420.80p | 284.00p | 300.00p | Reiteration |
| 24-Oct-25 | Citigroup | Buy | 442.40p | 470.00p | 500.00p | Reiteration |
| 17-Oct-25 | UBS | Neutral | 399.70p | - | 380.00p | Reiteration |
| 11-Aug-25 | JP Morgan Cazenove | No Recommendation | 375.60p | - | - | Reiteration |
| 01-Aug-25 | RBC Capital Markets | Outperform | 361.60p | 440.00p | 440.00p | Reiteration |
| 21-Jul-25 | Deutsche | Buy | 355.60p | 425.00p | 435.00p | Reiteration |
| 18-Apr-24 | Jefferies | Buy | 412.90p | - | 600.00p | Reiteration |
| 08-Sep-23 | Peel Hunt Limited | Hold | 589.00p | - | 629.00p | Reiteration |
| 03-Jul-23 | Barclays | Overweight | 609.60p | 650.00p | 700.00p | Reiteration |
| 17-May-23 | HSBC | Hold | 647.40p | - | 665.00p | Reiteration |
| 22-Mar-23 | Exane BNP Paribas | Neutral | 560.20p | - | 555.00p | Upgrade |
| 16-Mar-23 | Numis | Hold | 553.60p | - | 470.00p | Reiteration |
| 01-Feb-23 | Redburn Partners | Buy | 491.20p | - | - | New Coverage |
| 14-Nov-22 | Shore Capital | Overweight | 533.60p | - | - | Reiteration |
| 11-May-22 | Morgan Stanley | Overweight | 508.00p | - | - | Reiteration |
| Currency | UK Pounds |
| Share Price | 410.70p |
| Change Today | -3.50p |
| % Change | -0.85 % |
| 52 Week High | 442.40p |
| 52 Week Low | 309.50p |
| Volume | 5,015,683 |
| Shares Issued | 2,526.04m |
| Market Cap | £10,374m |
| RiskGrade | 127 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Strong Buy | 5 |
| Buy | 2 |
| Neutral | 9 |
| Sell | 1 |
| Strong Sell | 1 |
| Total | 18 |

| Latest | Previous | |
|---|---|---|
| Interim | Final | |
| Ex-Div | 14-Aug-25 | 03-Apr-25 |
| Paid | 22-Sep-25 | 14-May-25 |
| Amount | 4.15¢ | 5.93p |
| Time | Volume / Share Price |
| 19:00 | 131,097 @ 410.70p |
| 17:00 | 4,133 @ 410.70p |
| 16:51 | 415,420 @ 410.63p |
| 16:49 | 415,420 @ 410.63p |
| 16:37 | 2 @ 410.70p |
| CEO | Andy M. Ransom |
| Chair | Richard Solomons |
| CFO | Paul Edgecliffe-Johnson |
You are here: research